Skip to main content
Log in

German-austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy

  • Ongoing Clinical Trial
  • Published:
Blut Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

CHOP:

Cyclophosphamide, Hydroxyldaunomycin, Oncovine, Prednison

COP-BLAM:

Cyclophosphamide, Oncovine, Prednison, Bleomycin, Adiamycin, Matulan

IMVP-16:

Ifosphamide, Methotrexate, VP-16

References

  1. Armitage JC, Weisenberger DD, Hutchins M, et al. (1986) Chemotherapy for diffuse large cell lymphoma — rapidly responding patients have more durable remissions. J Clin Oncol 4: 160–164

    Google Scholar 

  2. Browne MJ, Hubbard SM, Longo DL, et al. (1986) Excess prevalence of pneumocystis carinii pneumonia in patients treated for lymphoma with combination chemotherapy. Ann Intern Med 104: 338–344

    Google Scholar 

  3. Cabanillas F, Hagemeister FB, Bodey GB, et al. (1982) IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 60: 693–697

    Google Scholar 

  4. Coltman CA, Dahlberg S, Jones SE, et al. (1986) CHOP is curative in thirty percent of patients with diffuse large cell lymphoma: a twelve year Southwest Oncology Group follow up. Proc Am Soc Clin Oncol 5: 197 (abstract)

    Google Scholar 

  5. Fisher RI, DeVita VT, Hubbard SM, et al. (1983) Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of Pro MACE and MOPP chemotherapy. Ann Intern Med 98: 304–309

    Google Scholar 

  6. Gerhartz HH, Thiel E, Hiller E, et al. (1986) Vergleich der CHOP- und COP-BLAM-Chemotherapie hochmaligner Non-Hodgkin-Lymphome. Dtsch Med Wochenschr 111: 1511–1515

    Google Scholar 

  7. Goldie JH, Coltman AJ (1979) A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–1731

    Google Scholar 

  8. Goldstone AH, Gribben J, Dones L (1987) Forth report of EBMT experience of autologous bone marrow transplantation in lymphoma. Bone Marrow Transpl 2 (Suppl. 1): 200 (abstract)

    Google Scholar 

  9. Groopman JE, Mitsuyashu RT, DeLeo MJ, et al. (1987) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the aquired immunodeficiency syndrome. N Engl J Med 317: 593–598

    Google Scholar 

  10. Klimo P, Connors JM (1985) MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann Intern Med 102: 596–602

    Google Scholar 

  11. Laurence J, Coleman M, Allen SL, et al. (1982) Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. Ann Intern Med 97: 190–195

    Google Scholar 

  12. Lennert K (1981) Histopathology of non-Hodgkin's lymphomas. Springer Verlag, Berlin Heidelberg New York

    Google Scholar 

  13. McKelvy EM, Gottlieb JA, Wilson HE, et al. (1976) Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38: 1484

    Google Scholar 

  14. Miller TP, Dana BW, Weick JK, et al. (1987) Southwest Oncology Group clinical trials for intermediate and high grade non-Hodgkin's lymphomas. 3rd International Conference Malignant Lymphoma, Lugano, abstract book, p 55

  15. Willemze R, Peters WG, Hennik MB van, et al. (1985) Intermediate and high dose AraC and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin's lymphoma. Scand J Haematol 34: 83–87

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

(NHL-Study Group)

Coordination Committee: G. Brittinger, R. Heinz, D. Huhn, P. Meusers, W. Siegert, A. Stacher, E. Thiel, W. Wilmanns

Supported by BMFT No. 01ZP024

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerhartz, H.H., Thiel, E., Brittinger, G. et al. German-austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy. Blut 56, 139–142 (1988). https://doi.org/10.1007/BF00320022

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00320022

Keywords

Navigation